Introduction
Currently, obstetricians and gynecologists often struggle to treat vaginitis, which is one of the most common problems in clinical medicine. This problem affects women of various ages during their reproductive stage and menopause. Commonly, it is defined as a change in the normal vaginal bacterial flora, in which the normal Lactobacilli production is disturbed and, consequently, leads to the overgrowth of a predominant anaerobic bacteria species, such as Gardnerella vaginali, Protea spp., Bacteroides spp., Mobiluncus spp., Gram-positive bacteria, and Mycoplasma, which can lead to serious complications. 1 Untreated vaginal infection can result in chronic infection of the vagina, and when the infection reaches the fallopian tubes and cervix, infertility can occur. Maintaining a healthy vaginal ecosystem remains an issue underestimated by both patients and the doctors treating them. Most of the cases of vaginitis are caused by candidiasis, trichomoniasis and bacterial vaginosis. 2, 3 The pathomechanisms responsible for the bacterial and fungal infections remain unknown. The most significant role in the elimination of vaginal inflammation (VI) is played by non-specific immunity: macrophages, natural killer (NK) cells and neutrophils. Eosinophils indifference and other humoral factors (lysozyme, low pH) constitute a barrier and play an important role in long-term humoral immune protection. However, specific immunity based on the production of antibodies does not serve an important function in VI. Bacterial vaginosis is caused by an imbalance in bacteria colonizing the vagina. A characteristic feature of bacterial vaginosis is the lack of leukocyte infiltration. It is thought that succinic acid and acetic acid are secreted by the bacteria in order to suppress the local immune response. However, in recurrent infections of the vagina and cervix, immune disorders are diagnosed by increased levels of heat shock proteins. This indicates that the normal immune status of women may be imperative in preventing the development of vaginal infections. However, this problem is more complicated, particularly when the immunological system is impaired through disease, immunosuppressants or cancer. 4 Some authors have highlighted the role of cytokines (e.g., recombinant proinflammatory cytokines) in the immune response to fungal pathogens and bacterial infections, and their potential use for prevention or treatment of fungal infections. 5 The most common cause of vaginal infection is due to a chronic disorder of the vaginal ecosystem. Normal microflora of the vagina, which consists of naturally occurring bacteria in the reproductive tract -primarily of the Lactobacillus genus -is essential for the protection of these areas. These bacteria maintain an acidic environment (pH 3.8-4.5) in the vagina and produce substances that prevent the growth of pathogenic bacteria and fungi. Disturbance of the vaginal ecosystem and the reduction in the number of these bacteria contributes to the development of vaginal infections. 1, 3 Therefore, treatment of vaginal infections with antibiotic or antifungal drugs is often successful only for a limited time, as the root cause of the problem, the disrupted ecosystem of the vagina, remains unaddressed. For this reason, it is important to discover and develop new therapeutic compounds to improve the treatment of vaginal infections. In recent years, interest in the use of plant or animal extracts for the production of pharmacological compounds has increased. Additionally, numerous studies have shown that natural components can prevent different diseases. [6] [7] [8] [9] The introduction of new natural substances with medicinal properties can increase the effectiveness and quality of treatment. Therefore, we decided to evaluate another natural substance for vaginitis treatment: an extract from the plant Calophyllum inophyllum, tamanu oil. It contains a lot of unsaturated acids, which are necessary, i.a., to keep the skin healthy and properly hydrated. We hypothesize that this examined extract can be used as a potential therapeutic factor for healing wounds in gynecological diseases as well as protecting mucous membrane integrity. Additionally, we used the electroporation (EP) process to improve therapeutic effects of the tested compound. Electroporation has been widely utilized in recent years as a safe and effective technique to successfully deliver drugs into target cells for both experimental and therapeutic approaches.
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Material and methods
Cell culture
The established fibroblast cell line (Normal Human Dermal Fibroblasts -NHDF; PromoCell, Biomedica Poland, Piaseczno, Poland) and normal human primary fibroblast isolated from the vaginal mucus fragment (human vaginal fibroblasts -HVFs) of a healthy patient were used. The primary human fibroblasts were used as a comparison to the established human fibroblast line. The cell lines were grown in Dulbecco's Modified Eagle Medium (DMEM) (Sigma-Aldrich, St. Louis, USA) containing 2mM glutamine, 50 µg/mL streptomycin and 10% fetal bovine serum. Cells were incubated at 37°C in 5% CO 2 . The culture medium was replaced twice a week. Before every experiment, cells were detached by 0.25% trypsin with 0.02% ethylenedinitrilotetraacetic acid (EDTA) (Sigma-Aldrich). The appropriate dilutions (1:2-1:100) of tamanu oil, the pure extract from the plant C. inophyllum, were prepared in cell culture medium and examined.
Electroporation
Cells were grown as monolayers in 75 cm 2 flasks; then they were trypsinized and centrifuged (5 min, 1000 rpm). Next, cells were counted to obtain the volume of 3 × 10 6 /mL and resuspended in 200 μL of EP buffer was observed only for further dilutions (1:20; 1:50; 1:100) ( Fig. 1 ). From the experiment in which different currents were used, we selected the electric field of 800 V/cm intensity as the most beneficial for further experiments with the application of the oil extract from C. inophyllum on both cell lines (Fig. 2) . Surprisingly, combining EP with tamanu oil resulted in a much greater increase in cell proliferation of HVF cells compared to NHDF cells. The highest proliferation was observed at 800 V/cm electrical field intensity and 1:10 dilution of tamanu oil (Fig. 3) . with a low electrical conductivity of 0.14 S/m (10mM KH 2 PO 4 /K 2 HPO 4 , 1mM MgCl 2 , and 250mM sucrose; pH 7.4). The cell suspension was pulsed in a cuvette with 2 aluminum plate electrodes (4 mm space between electrodes) with electrical field strength up to 3,000 V/cm using 8 pulses of 100 µs duration. Rectangular electrical pulses were delivered by an electroporator ECM 830 (BTX Harvard Apparatus; Syngen Biotech, Wrocław, Poland). In the case of the cells being treated with tamanu oil and undergoing EP, electrical fields with the intensity of 800 and 1,000 V/cm were used. Following pulsation, the cells were left for 10 min at 37°C, centrifuged, resuspended in fresh cell culture medium, and reseeded for a viability assay and immunocytochemistry (ABC method).
Cellular viability
Cellular viability was studied by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (In Vitro Toxicology Assay; Sigma-Aldrich), which assesses the mitochondrial redox activity as an indicator of the cellular proliferation potential. The MTT assay was performed 24 h and 72 h post-treatment, according to the manufacturer's protocol. The absorbance was measured at 570 nm using a multiwell plate reader (EnSpire Multimode Reader; Perkin Elmer Polska, Kraków, Poland). The assay was performed independenly 3 times using 3 repetition samples, and the mean values and standard deviation (SD) of combined results were calculated.
Immunocytochemical ABC staining of collagen III and mitochondrial superoxide dismutase
The expression of selected proteins was examined by the immunocytochemical Avidin-Biotin Complex (ABC) method. After fixation in 4% paraformaldehyde, the samples were permeabilized and blocked by incubation with 0.1% Triton X-100 (Sigma-Aldrich) in phosphate-buffered saline (PBS). The protein expression was visualized with a polyclonal antibody COL-III (1:100, anti-collagen III) and anti-SOD2 (Santa Cruz Biotechnology, Dallas, USA). Immunocytochemical staining was performed with ImmPRESS Universal Reagent (Vector Laboratories, Burlingame, USA).
Results
Cellular viability
The influence of tamanu oil, electric field intensity and the combination of both on cellular viability was assessed using MTT assay. The investigation indicated that using the tamanu oil increased viability in human fibroblast cell line, stimulating the proliferation of NHDF cells at every dilution, in contrast to HVF cells, in which higher viability 
Immunocytochemical ABC reaction: collagen III and MnSOD
The results of immunostaining with anti-collagen III and anti-mitochondrial superoxide dismutase 2 (anti-Mn-SOD2) are presented in Tables 1-4 and in Fig. 4 and 5 . An increase in collagen III expression was noted only 24 h post-incubation with tamanu oil (Table 1, Fig. 4) . The most intense immune reaction was observed after incubation with tamanu oil at a dilution of 1:10 with application of an electric field of 800 V/cm intensity (c.a. 70% for NHDF and 30% for HVF) after 24 h of incubation. After 72-hour incubation with tamanu oil in combination with EP, the level of COL-III insignificantly decreased in NHDF cells and increased in primary HVF cells (Table 1, Fig. 4 ). Contrary to collagen III, the MnSOD expression indicated more intense staining reaction. The intensity of anti-MnSOD reaction increased proportionally with the increasing electric field intensity (Tables 1,2, Fig. 5 ) in NHDF cells. The highest expression was noted after a 24-hour incubation for cells treated only with tamanu oil and for cells treated with oil-EP combination (90% and 100%, respectively) ( Table 1, Fig. 5 ). The expression of this antioxidant enzyme was lower after 72 h than 24 h post-treatment for cells treated only with tamanu oil and for the combined treatment (Table 2, Fig. 5) . In HVF cells, the expression of MnSOD also increased at the higher EP parameters after 72 h in 100% of cells (Tables 3,4) .
Discussion
Prognosis of vaginitis in many cases is promising, but most of the infections are not completely cured and, therefore, reoccur. The recurring vaginal infection might lead to chronic infections and scarring, 10 but in most cases when suitably treated do not cause permanent problems. Conversely, untreated vaginal infections can spread to other pelvic structures and result in chronic diseases. 11 In such cases, another course of treatment is necessary. Natural compounds are commonly applied in many diseases of the human body, against both the precancerous state and cancer. However, it is commonly known that some of these compounds can be used in other non-cancer diseases. As an example can serve tropical tamanu oil, an extract from C. inophyllum. The properties of this oil have been known for a long time, especially for healing wounds. Women frequently use tamanu oil to achieve healthy, clear skin, as it helps to clear acne and scars. These compounds control cells tamanu oil tamanu oil + 800 V/cm tamanu oil + 1,000 V/cm 24 h only for the electric field strength of 800 V/cm. A higher electric field intensity caused a similar effect in the control non-treated cells. Our results indicated that it stimulated cell proliferation, which suggests that tamanu oil could become a promising agent for human fibroblast re-growth. Therefore, it could help in developing a new, more effective method in vaginitis treatment. During the healing phase (so-called "proliferation") collagen and elastin fibers are formed to build up a strong and flexible skeleton, which is then filled by proteoglycan molecules and glycoproteins that combine matrix and healing cells in the wound. 12, 13 In order to verify the healing properties of the chosen natural oil, the expression of selected extracellular matrix protein (collagen III) was examined. An increase of collagen III expression was noted 24 h and 72 h after incubation with the extract from C. inophyllum seeds. The highest expression was observed after incubation with tamanu oil at a dilution of 1:10, with a pulsed electric field (800 V/cm). Higher (1,000 V/cm) EP parameters induced decrease of immunoassayed reaction with anti-collagen III, suggesting that the higher EP parameters in combination with tamanu oil do not support collagen expression in NHDF and HVF cells. Initial wound healing involves the synthesis of type III collagen, which is characteristic for immature connective tissue. As wound healing progresses, type III collagen, which is the main component of the granulation tissue, is replaced by type I collagen. Type I collagen is the main and most common type present in dermal tissue and is responsible for the tensile strength of the tissue. 14 Our results suggest that tamanu oil can aid in early stages of the healing process by increasing the expression of type III collagen by human fibroblasts. In wound healing and inflammatory processes, the development of scar remodeling is important in order to obtain a sufficiently strong substitute tissue that is resistant to mechanical stimuli. 15, 16 The synthesis of collagen proteins is a very complex process, which is dependent on the level of the natural antioxidant, vitamin C. 17, 18 Thus, the expression of main antioxidant enzyme MnSOD was evaluated. The MnSOD protein content was found to increase with increasing pulsed electric field intensity combined with tamanu oil use, in comparison to control non-treated cells.
Conclusions
It has been shown that the C. inophyllum extract stimulates the proliferation of established and primary fibroblasts to a different degree. The use of tamanu oil at the concentrations indicated by this study suggests that the stimulated proliferation process could be utilized as an anti-inflammatory, analgesic and antiseptic agent in the healing process (increased expression of collagen type III) of vaginal infections. Moreover, tamanu oil is known for its strong antimicrobial properties. The obtained results might be the basis for the future development of protocols involving the application of the EP method combined with the oil extract from C. inophyllum in preclinical and clinical treatment.
